Once-Monthly Injections for Schizophrenia, Dementia Gain Approval Pharmaceutical companies race to develop long-acting ...

Chez les patients n'ayant jamais pris d'aripiprazole, la tolérance de l'aripiprazole oral doit être établie avant l'instauration du traitement par Abilify Maintena. Abilify Maintena ne nécessite pas ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Abilify Asimtufii? Abilify Asimtufii contains the ...

Finished-dose manufacturers are forecast to represent 72.0% share in 2026, led by dossier ownership and batch-release accountability. Direct supply is projected to hold 68.0% share in 2026, influenced ...

One paper compares aripiprazole, cariprazine and brexpiprazole for first-episode use. Another measures long-term outcomes for an aripiprazole monthly injectable. Schizophrenia is a chronic and ...

The cost of Abilify Maintena can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Abilify Maintena. As with ...

Older adults with dementia (loss of memory and brain function) have an increased chance of death if treated with antipsychotic medications such as aripiprazole.Older adults with dementia may also have ...

Health Canada has issued a notice of compliance to Otsuka Canada Pharmaceutical Inc. (OCPI) and Lundbeck Canada Inc. (Lundbeck) approving the use of their long-acting injectable (LAI) antipsychotic ...

A long-acting version of aripiprazole injection with improved dosing frequency for treating schizophrenia and bipolar disorder has been introduced in Korea. The Ministry of Food and Drug Safety ...